Camargo Appoints COO - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Camargo Appoints COO



Untitled Document

Jim Beach, a veteran health care executive, has been named chief operating officer for Camargo Pharmaceutical Services, a drug- development organization specializing in the 505(b)(2) approval pathway.

Prior to joining Camargo, Beach had been vice-president of marketing and product management for scientific products for Cardinal Health, vice-president of market insights and a member of the US management board for Ethicon Endo-Surgery, and leader of the global product company program for GE Healthcare.

Source: Camargo Pharmaceutical Services

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here